KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Short-Term Debt issuances (2016)

Astrana Health's Short-Term Debt issuances history spans 3 years, with the latest figure at $235000.0 for Q4 2016.

  • For Q4 2016, Short-Term Debt issuances rose 413.33% year-over-year to $235000.0; the TTM value through Sep 2018 reached $235000.0, up 130.72%, while the annual FY2017 figure was $5.0 million, N/A changed from the prior year.
  • Short-Term Debt issuances for Q4 2016 was $235000.0 at Astrana Health, up from -$1.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $270000.0 in Q2 2012 and bottomed at -$1.0 million in Q1 2016.
  • The 3-year median for Short-Term Debt issuances is $80000.0 (2015), against an average of -$142500.0.
  • The largest YoY upside for Short-Term Debt issuances was 413.33% in 2016 against a maximum downside of 413.33% in 2016.
  • A 3-year view of Short-Term Debt issuances shows it stood at $270000.0 in 2012, then crashed by 127.78% to -$75000.0 in 2015, then skyrocketed by 413.33% to $235000.0 in 2016.
  • Per Business Quant, the three most recent readings for ASTH's Short-Term Debt issuances are $235000.0 (Q4 2016), -$1.0 million (Q1 2016), and -$75000.0 (Q4 2015).